Bookrunners Piper Jaffray and Leerink Swann are assisting with sale
By Devika Patel
Knoxville, Tenn., July 19 - Anthera Pharmaceuticals, Inc. said it priced a $33 million registered public sale of stock. The deal was announced Wednesday and has a $4.95 million greenshoe.
The company will sell 33 million common shares. The price per share of $1.00 is a 24.81% discount to $1.33, the July 18 closing share price.
Piper Jaffray & Co. and Leerink Swann LLC are the joint bookrunning managers. Canaccord Genuity is the lead manager, and Summer Street Research Partners is the co-manager.
Settlement is expected July 24.
Proceeds will be used for general corporate purposes.
Anthera, based in Hayward, Calif., is a biopharmaceutical company.
| Issuer: | Anthera Pharmaceuticals, Inc.
|
| Issue: | Common stock
|
| Amount: | $33 million
|
| Greenshoe: | $4.95 million
|
| Shares: | 33 million
|
| Price: | $1.00
|
| Warrants: | No
|
| Bookrunners: | Piper Jaffray & Co. and Leerink Swann LLC
|
| Announcement date: | July 18
|
| Pricing date: | July 19
|
| Settlement date: | July 24
|
| Stock symbol: | Nasdaq: ANTH
|
| Stock price: | $1.33 at close July 18
|
| Market capitalization: | $46.83 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
